In T2DM requiring insulin initiation, icodec titrated with an app safely reduced HbA1c vs. daily basal insulin analogues at 52 wk

Aris Liakos; Thomas Karagiannis; Apostolos Tsapas

doi:10.7326/J23-0110

In T2DM requiring insulin initiation, icodec titrated with an app safely reduced HbA_1c vs. daily basal insulin analogues at 52 wk

Ann Intern Med. 2024 Jan;177(1):JC6. doi: 10.7326/J23-0110. Epub 2024 Jan 2.

Authors

Aris Liakos¹, Thomas Karagiannis¹, Apostolos Tsapas¹

Affiliation

¹ Aristotle University Thessaloniki, Thessaloniki, Greece (A.L., T.K., A.T.).

PMID: 38163368
DOI: 10.7326/J23-0110

Abstract

Bajaj HS, Aberle J, Davies M, et al. Once-weekly insulin icodec with dosing guide app versus once-daily basal insulin analogues in insulin-naive type 2 diabetes (ONWARDS 5): a randomized trial. Ann Intern Med. 2023;176:1476-1485. 37748181.

Publication types

Comment

MeSH terms

Blood Glucose
Diabetes Mellitus, Type 2* / complications
Diabetes Mellitus, Type 2* / drug therapy
Drug Administration Schedule
Glycated Hemoglobin
Humans
Hypoglycemic Agents / therapeutic use
Insulin / therapeutic use
Mobile Applications*

Substances

Insulin
Hypoglycemic Agents
Blood Glucose
Glycated Hemoglobin